Cargando…

Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Velcheti, Vamsidhar, Pennell, Nathan A, Rakshit, Sagar, Stevenson, James, Shapiro, Marc, Almeida, Francisco A, Gurajala, Ram, Schalper, Kurt Alex, Saunthararajah, Yogen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645121/
http://dx.doi.org/10.1186/2051-1426-3-S2-P178
_version_ 1782400766909087744
author Velcheti, Vamsidhar
Pennell, Nathan A
Rakshit, Sagar
Stevenson, James
Shapiro, Marc
Almeida, Francisco A
Gurajala, Ram
Schalper, Kurt Alex
Saunthararajah, Yogen
author_facet Velcheti, Vamsidhar
Pennell, Nathan A
Rakshit, Sagar
Stevenson, James
Shapiro, Marc
Almeida, Francisco A
Gurajala, Ram
Schalper, Kurt Alex
Saunthararajah, Yogen
author_sort Velcheti, Vamsidhar
collection PubMed
description
format Online
Article
Text
id pubmed-4645121
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46451212015-11-20 Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer Velcheti, Vamsidhar Pennell, Nathan A Rakshit, Sagar Stevenson, James Shapiro, Marc Almeida, Francisco A Gurajala, Ram Schalper, Kurt Alex Saunthararajah, Yogen J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645121/ http://dx.doi.org/10.1186/2051-1426-3-S2-P178 Text en Copyright © 2015 Velcheti et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Velcheti, Vamsidhar
Pennell, Nathan A
Rakshit, Sagar
Stevenson, James
Shapiro, Marc
Almeida, Francisco A
Gurajala, Ram
Schalper, Kurt Alex
Saunthararajah, Yogen
Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title_full Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title_fullStr Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title_full_unstemmed Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title_short Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
title_sort novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645121/
http://dx.doi.org/10.1186/2051-1426-3-S2-P178
work_keys_str_mv AT velchetivamsidhar novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT pennellnathana novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT rakshitsagar novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT stevensonjames novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT shapiromarc novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT almeidafranciscoa novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT gurajalaram novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT schalperkurtalex novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer
AT saunthararajahyogen novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer